What are the specific molecular mechanisms by which AQP4 dysfunction contributes to CNS disorder pathogenesis?

PARTIALLY ADDRESSED

The abstract states that AQP4 'is part of the pathogenesis' of CNS disorders and shows 'notable variability' in these conditions, but the precise causal mechanisms linking AQP4 alterations to disease development remain unexplained. Understanding these mechanisms is critical for developing AQP4-targeted therapeutics. Gap type: unexplained_observation Source paper: Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. (2023, Neurobiol Dis, PMID:36796590)

Priority: 0.80 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What are the specific molecular mechanisms by which AQP4 dysfunction contributes to CNS disorder pathogenesis? is a 0.8 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What are the specific molecular mechanisms by which AQP4 dysfunction contributes to CNS disorder pathogenesis? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (1)

AQP4→COMPLEMENT CASCADE

associated with (5)

AQP4→CSF-ISF ExchangeAQP4→Glymphatic SystemAQP4→Sepsis-Associated EncephalopathyAQP4→Neuromyelitis Optica Spectrum DisorderAQP4→NEUROMYELITIS OPTICA SPECTRUM DISORDER

binds (5)

AQP4→Aquaporin-4-IgGcalmodulin→AQP4IGG AUTOANTIBODY→AQP4AQP4-ANTIBODY→AQP4AQP4-Ab→AQP4

biomarker for (4)

AQP4→Neuromyelitis OpticaAQP4→NEUROMYELITIS OPTICA SPECTRUM DISORDERAQP4→NMOSDAQP4→Neuromyelitis Optica Spectrum Disorder

component of (2)

AQP4→Glymphatic PathwayAQP4→Glymphatic System

data in (1)

ds-f2c28aed24a7→AQP4

describes (1)

cell-types-nodes-ranvier-neurod→CNS

detects glymphatic dysfunction (1)

H5_AQP4→AQP4

encodes (1)

AQP4→AQP4

enhances function (1)

H2→AQP4

expressed in (3)

AQP4→Astrocytic EndfeetAQP4→Astrocyte EndfeetAQP4→Central Nervous System

implicated in (1)

AQP4→demyelination

inhibits (2)

AQP4→NF-κB PathwayAQP4→Astrocytic Autophagy

involved in (5)

AQP4→CNS edemaAQP4→Glymphatic PathwayAQP4→Glymphatic DysfunctionAQP4→GLYMPHATIC SYSTEMAQP4→Beta-Amyloid Clearance

mediates (8)

AQP4→glymphatic pathwayAQP4→Perivascular Water TransportAQP4→CSF-ISF ExchangeAQP4→Glymphatic ClearanceAQP4→Glymphatic Transport
▸ Show 3 more

promotes (1)

AQP4→brain edema

protects against (1)

AQP4→Tau Aggregation

provides data for (1)

AQP4→ds-f2c28aed24a7

regulates (4)

AQP4→Tau ClearanceAQP4→Amyloid Beta ClearanceAQP4→CHI3L1B Cells→AQP4

targets (1)

TGN-020→AQP4

upregulates (1)

Cecal Ligation and Perforation→AQP4
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps